The House and Senate Committees on Appropriations have approved FY2026 Agriculture appropriations bills [3] (H.R. 4121 [4] and S. 2256 [5]) that would similarly redefine the statutory definition of hemp to restrict the commercial production, sale, and distribution of certain hemp-derived cannabinoid products. House appropriators have expressed that the provision would close "the hemp loophole that has resulted in the proliferation of unregulated intoxicating hemp products [6]." During Senate committee markup [7], Senator Mitch McConnell expressed that the existing hemp definition has resulted in "an unintended consequence that has allowed for intoxicating hemp-derived synthetic products to be made and sold," calling for changes to reflect "the original intent of the 2018 farm bill [7]" by closing the loophole. The Senate provision would delay implementation for one year; the House provision does not include this delay. Similar action was debated [8] but not enacted in the 118th Congress.
Links
[1] https://www.congress.gov/crs-product/IN12565?q=%7B%22search%22%3A%22hemp%22%7D&s=1&r=5
[2] http://www.rethinkpot.org/FY26AGBill
[3] https://www.congress.gov/crs-product/R48564
[4] https://www.congress.gov/bill/119th-congress/house-bill/4121
[5] https://www.congress.gov/bill/119th-congress/senate-bill/2256
[6] https://appropriations.house.gov/news/press-releases/committee-releases-fy26-agriculture-rural-development-fda-bill
[7] https://www.appropriations.senate.gov/hearings/full-committee-markup-of-commerce-justice-science-agriculture-rural-development-fda-and-legislative-branch-appropriations-acts
[8] https://www.congress.gov/crs-product/IN12381